These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6125464)

  • 21. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone.
    Rajfer J; Handelsman DJ; Swerdloff RS; Hurwitz R; Kaplan H; Vandergast T; Ehrlich RM
    N Engl J Med; 1986 Feb; 314(8):466-70. PubMed ID: 2868413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is hormonal therapy necessary in prepubertal boys with cryptorchidism?
    Shima H; Okamoto E; Terakawa T; Ohnishi Y; Ikoma F
    Int Urol Nephrol; 1991; 23(6):605-9. PubMed ID: 1685151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does treatment with human chorionic gonadotropin induce reversible changes in undescended testes in boys?
    Demirbilek S; Atayurt HF; Celik N; Aydin G
    Pediatr Surg Int; 1997; 12(8):591-4. PubMed ID: 9354732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cryptorchism. Treatment with human chorionic gonadotropin or gonadotropin-releasing hormone?].
    Christiansen P; Müller JR; Buhl SB; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PI; Kastrup KW; Nielsen K; Nielsen LB
    Ugeskr Laeger; 1993 Oct; 155(41):3287-90. PubMed ID: 7903008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional study of cryptorchidism in children: testicular volume and hormonal function at 18 years of age.
    Varela-Cives R; Mendez-Gallart R; Estevez-Martinez E; Rodriguez-Barca P; Bautista-Casasnovas A; Pombo-Arias M; Tojo-Sierra R
    Int Braz J Urol; 2015; 41(1):57-66. PubMed ID: 25928530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Endocrine data in cryptorchism].
    Gendrel D; Job JC; Canlorbe P; Roger M; Laclyde JP
    Arch Fr Pediatr; 1978 May; 35(5):535-45. PubMed ID: 28100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism.
    Cortes D; Thorup J; Visfeldt J
    J Urol; 2000 Apr; 163(4):1290-2. PubMed ID: 10737531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-palpable testes. Orchiopexy in single stage.
    Canavese F; Cortese MG; Gennari F; Gesmundo R; Lala R; De Sanctis C; Costantino S
    Eur J Pediatr Surg; 1995 Apr; 5(2):104-5. PubMed ID: 7612577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The medical treatment of cryptorchism in early childhood].
    Lala R; Canavese F; Matarazzo P; Chiabotto P; De Sanctis C
    Pediatr Med Chir; 1991; 13(1):73-5. PubMed ID: 1675784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human chorionic gonadotrophin hormone for treatment of congenital undescended testis: Anatomical barriers to its success.
    Elsherbeny MS; Abdelhay S
    J Pediatr Surg; 2019 Nov; 54(11):2413-2415. PubMed ID: 30867099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of prepubertal cryptorchism. Clinical experiences with LH-RH treatment].
    Höcht B
    Fortschr Med; 1983 Sep; 101(34):1531-5. PubMed ID: 6138302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal therapy for cryptorchidism with a combination of human chorionic gonadotropin and follicle-stimulating hormone. Success and relapse rate.
    Saggese G; Ghirri P; Gabrielli S; Cosenza GC
    Am J Dis Child; 1989 Aug; 143(8):980-2. PubMed ID: 2569267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does HCG treatment induce inflammation-like changes in undescended testes in boys?
    Hjertkvist M; Läckgren G; Plöen L; Bergh A
    J Pediatr Surg; 1993 Feb; 28(2):254-8. PubMed ID: 8094747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial.
    Schwentner C; Oswald J; Kreczy A; Lunacek A; Bartsch G; Deibl M; Radmayr C
    J Urol; 2005 Mar; 173(3):974-7. PubMed ID: 15711353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histologic maldevelopment of unilaterally cryptorchid testes and their descended partners.
    Huff DS; Hadziselimovic F; Snyder HM; Blythe B; Ducket JW
    Eur J Pediatr; 1993; 152 Suppl 2():S11-4. PubMed ID: 8101802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteinising hormone-releasing hormone nasal spray as therapy for undescended testicle.
    Pirazzoli P; Zappulla F; Bernardi F; Villa MP; Aleksandrowicz D; Scandola A; Stancari P; Cicognani A; Cacciari E
    Arch Dis Child; 1978 Mar; 53(3):235-8. PubMed ID: 25629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal treatment of undescended testis.
    Toublanc JE
    Prog Clin Biol Res; 1985; 203():207-11. PubMed ID: 2870509
    [No Abstract]   [Full Text] [Related]  

  • 38. Cryptorchidism: treatment with human chorionic gonadotropin--a Venezuelan experience.
    Osuna JA; Arata de Bellabarba G; Temponi AF; Osuna A; Marín CR
    Arch Androl; 1997; 39(3):229-35. PubMed ID: 9352035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind, placebo-controlled study of luteinising-hormone-releasing-hormone nasal spray in treatment of undescended testes.
    deMuinck Keizer-Schrama SM; Hazebroek FW; Matroos AW; Drop SL; Molenaar JC; Visser HK
    Lancet; 1986 Apr; 1(8486):876-80. PubMed ID: 2870353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of cryptorchidism by intranasal synthetic luteinising-hormone releasing hormone. Results of a collaborative double-blind study.
    Illig R; Exner GU; Kollmann F; Kellerer K; Borkenstein M; Lunglmayr L; Kuber W; Prader A
    Lancet; 1977 Sep; 2(8037):518-20. PubMed ID: 95729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.